ctrl K

Price Alert

Tango Therapeutics Inc. (TNGX)

NASDAQ: TNGX · Real-Time Price · USD

6.94

0.11 (1.61%)

At close: Sep 05, 2025, 3:59 PM

7.07

1.87%

After-hours: Sep 05, 2025, 05:38 PM EDT

Tango Therapeutics Revenue Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Dec 31, 2021	Sep 30, 2021
Collaboration Revenue Revenue	3.18M	5.39M	18.36M	11.61M	7.78M	11.2M	10.73M	9.6M	6.41M	6.92M	5.77M	5.72M	6.79M
Collaboration Revenue Revenue Growth	-41.01%	-70.64%	+58.20%	+49.29%	-30.56%	+4.33%	+11.81%	+49.71%	-7.36%	+19.91%	+0.96%	-15.78%	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	11.34M	11.48M	11.09M	11.22M	10.77M	10.66M	9.11M	9.21M	9.17M	8.01M	7.89M	8.1M	7.23M	6.81M	6.07M	4.43M	3.63M	3.47M	3.02M	2.52M	2.38M	1.95M
Selling, General, and Administrative Revenue Growth	-1.21%	+3.52%	-1.18%	+4.17%	+1.05%	+17.09%	-1.13%	+0.38%	+14.49%	+1.60%	-2.62%	+11.99%	+6.24%	+12.22%	+36.84%	+22.12%	+4.70%	+14.95%	+19.78%	+5.89%	+21.76%	n/a
Research and Development Revenue	32.18M	36.44M	33.94M	33.26M	38.65M	38.06M	31.34M	27.15M	28.67M	28.04M	29.09M	28.74M	23.74M	24.33M	21.63M	21.92M	19.08M	15M	15.06M	12.98M	11.13M	10.82M
Research and Development Revenue Growth	-11.69%	+7.38%	+2.03%	-13.95%	+1.55%	+21.46%	+15.43%	-5.31%	+2.25%	-3.62%	+1.21%	+21.07%	-2.42%	+12.46%	-1.32%	+14.91%	+27.19%	-0.42%	+16.07%	+16.61%	+2.84%	n/a